coronavirus, Covid-19, Health, National Academy of Medicine’s report , CAGR of 15.8 percent

Globally physicians have been overworked for decades, and the COVID-19 pandemic has amplified this burnout. The pandemic threw light on the susceptibility of physicians to burnout and the lack thereof of robust healthcare systems to support such situations.

While physicians have tirelessly worked to save lives during this ongoing pandemic, there have been innumerable breakdowns due to the helplessness and overwork they experienced during these times. A recent research reported that in India doctors were 1.64 times and the support staff were five times more likely to experience pandemic-related burnout.

Here are five potential upcoming post-pandemic trends and how technology might enable physicians in the delivery of care.

Team-based Care

The National Academy of Medicine’s report identifies ‘team-based care’, defined by at least two healthcare providers caring for a patient, as the possible remedy for alleviating physician burnout, thereby increasing care accountability, and improving the quality of care.

Once the pandemic is put behind us, there would be many patients that would require sustained care with even more focus on co-morbid patients; thus, the team-based care approach might gain momentum. This might also manifest itself in the creation and consolidation of more physician groups, hospital chains, and/or State-managed control hubs for managing healthcare effectively.

It will become increasingly important that proper patient documentation be maintained, and shared electronically in an interoperable method. Technology can help with effective data management and information sharing that could take the load off the physicians — thereby increasing accuracy, mitigating errors and optimising efficiency.

Health organisations can deploy technology solutions like Natural language Processing (NLP), Clinical Decision Support Systems (CDSS), and Machine learning (ML) to improve the efficiency of the data. Web-based programmes that encourage collaborative care, patient engagement and self-management could be key to reducing the burden on the physicians, improving patient safety and patient outcomes.

Access To Remote Care

Virtual visits and telemedicine have not been more important than they are today. With lockdowns in various stages since March 2020, telemedicine has been central to caring for patients in need of chronic care, co-morbid conditions, and OPT cases. Virtual visits have their merits in helping reduce physician burnout, as it allows them to care for their patients without burdening them with the responsibility of logistics. It has also allowed physicians to care for patients throughout the lockdown, making healthcare accessible to a wider pool of end users. With a combination of electronic health records, access to video-based consultation and convenience of receiving reports electronically, telemedicine is integral to healthcare now.

Skilling Medical Professionals

The pandemic has emphasised the large volume and skill gap that India faces within the healthcare profession. There are several technology start-ups that are taking cues from the Ed-tech industry and merging medical devices with latest software advances in visualisation, Artificial Intelligence (AI) and ML to create simulation solutions. One example is to leverage technology to automate mundane tasks around clinical documentation to free up valuable time for clinical specialists in addition to creating new jobs and career opportunities.

Electronic Medication Management

A physician’s workflow is considerably impacted with errors in prescription refill adding significantly to the workload. Electronic medicine management can help save a physician time for prescription refill approvals, help in medication management and patient adherence. Electronic medication management can also reduce the errors in prescription refills. Alerts could play an important role in allowing patients to adhere to the medication schedule thus improving the quality of care and drug compliance among patients.

Digital Medical Records

Patient safety is one of the core objectives of improved quality of care. Adverse events that occur due to unsuitable medication can be controlled through the help of technology. With digital health records and AI’s predictive analysis, healthcare organisations can manage adverse events in patients with chronic ailments and co-morbid conditions.

While digital health records allow physicians insights into the patient’s medical history, the data can also help in highlighting the possible side effects of medication, medication’s efficacy, and overall patient safety. This would save the physician hours of pouring over a patient’s medical paperwork. The key foundation building block will be digitisation of the data in an interoperable format.

A world where technology would be integral to all patient touch points is not far away. The healthcare IT industry is growing at a CAGR of 15.8 percent. Technology companies are working towards creating solutions for every challenge that physicians face and take over all the mundane tasks.

We are at the precipice of a world where physicians would be able to devote their time to direct patient care, as opposed to spending hours on tasks that can be outsourced to new and emerging technology solutions.

Sunil Raheja is Chief Operations Officer, IKS Health. Views are personal and do not represent the stand of this publication.


Japan travel news, japan travel guides, japan holiday destinations and japan reviews

LATEST NEWS

NEWS RELATED

Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners

Bharat Biotech’s Covaxin was granted restricted emergency use approval in ‘clinical trial mode’ on January 2. After suspending the proposed clinical trials of Bharat Bioetchs COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian company for the jab. The Brazilian health regulator’s decisioncomesafter…

Read more: Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners

Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19

“We expect results from the phase 4 study on itolizumab by the end of this quarter. This would be real-world data from around 300 patients,” said Arun Chandavarkar, Managing Director of Biocon Biologics (Representative image) Biocon Biologics, the subsidiary of Biocon on July 26 said that US-based Adagio Therapeutics has…

Read more: Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19

Jubilant Pharmova profit jumps 350% to Rs 160 crore in Q1FY22

On import alert issued by USFDA last week on the company’s Roorkee formulations manufacturing facility, the company said it was engaging with the agency and taking help of consultants to resolve the regulatory compliance issues. Jubilant Pharmova on July 13 reported net profit of Rs 160 crore in Q1FY22, a…

Read more: Jubilant Pharmova profit jumps 350% to Rs 160 crore in Q1FY22

Explained | Why UK expert panel advised against giving COVID-19 jabs to all children aged 12-17

The Joint Committee on Vaccination and Immunisation (JCVI), the UK’s top body of independent experts, has advised its government to defer vaccinating all children aged 12-17, saying only children at increased risk of serious COVID-19 disease should be offered the Pfizer-BioNTech vaccine. The JCVI, which is the equivalent of India’s…

Read more: Explained | Why UK expert panel advised against giving COVID-19 jabs to all children aged 12-17

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

Covaxin, Bharat Biotech Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based…

Read more: Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item

Biocon Biocon, on July 23, reported a 44 percent year-on-year (YoY) drop in net profit to Rs 84 crore in the first quarter ended June due to subdued API business and an exceptional item. Profit for the same period last year was Rs 149 crore. Net Profit stood at Rs…

Read more: Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item

India's smartphone market falls 13 pc sequentially in Q2 amid 2nd COVID wave: Canalys

Smartphone shipments in India fell 13 per cent to 32.4 million units in the April-June 2021 period over the previous quarter as the second wave of COVID-19 stifled demand, according to research firm Canalys. Given that the April-June 2020 had an almost two-month nationwide lockdown (amid the first wave of…

Read more: India's smartphone market falls 13 pc sequentially in Q2 amid 2nd COVID wave: Canalys

Gland Pharma on track to start production of Sputnik V jabs by November

Gland Pharma | Representative image Gland Pharma, a generic injectable focused pharmaceutical company, said it is on track to begin production of Sputnik V COVID-19 vaccines from October-November. Technology transfer of the drug substance to its manufacturing facility is under way, the company said. A dedicated manufacturing unit at Pashamylaram…

Read more: Gland Pharma on track to start production of Sputnik V jabs by November

Infosys reopens offices as India Inc eyes long road back to work

Here is what to know about clinical trials of COVID-19 vaccines involving children

Govt grants one-time exemption from revision of ceiling prices under NLEM

Private hospitals under scanner for slow pace of COVID-19 vaccination, procurement

Bharat Biotech faces hitches in scramble to raise Covaxin output

Oximeters, BP machines and 3 other devices to get cheaper as trade margins capped at 70%

Expect commercial supplies of Sputnik vaccine from Indian manufacturers by September: RDIF

How Nobel Hygiene, the Nashik-based diaper maker, carved a niche in a market dominated by MNCs

OTHER NEWS